A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients
Giorgia Massacci(University of Rome Tor Vergata), Francesca Sacco(Università Cattolica del Sacro Cuore), Giusj Monia Pugliese(Istituto Superiore di Sanità), Sara Latini(University of Rome Tor Vergata), Livia Perfetto(Sapienza University of Rome), Simone Graziosi(University of Rome Tor Vergata), Veronica Venafra(University of Rome Tor Vergata), Natalie Krahmer(Helmholtz Zentrum München), Valeria Bica(University of Rome Tor Vergata), Thomas Fischer(University Hospital Magdeburg), Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg), Martin Boettcher(Universitätsklinikum Erlangen), Felix Klingelhuber(Deutsches Diabetes-Zentrum e.V.)
Cited by 20
Related Papers
Rap1b is required for normal platelet function and hemostasis in mice
|Journal of Clinical Investigation|2005|307
Advancements and challenges in CAR T cell therapy in autoimmune diseases
|Nature Reviews Rheumatology|2024|203
Anti-CD19 CAR T cells for refractory myasthenia gravis
|The Lancet Neurology|2023|147